Document is current
Any future updates will be listed below
-
Authors
Tognoli, Maria Laura https://orcid.org/0000-0002-0640-0748
Vlahov, Nikola
Steenbeek, Sander
Grawenda, Anna M
Eyres, Michael
Cano‐Rodriguez, David https://orcid.org/0000-0002-2155-9159
Scrace, Simon
Kartsonaki, Christiana
von Kriegsheim, Alex https://orcid.org/0000-0002-4952-8573
Willms, Eduard
Wood, Matthew J
Rots, Marianne G
van Rheenen, Jacco https://orcid.org/0000-0001-8175-1647
O'Neill, Eric https://orcid.org/0000-0002-0060-6278
Pankova, Daniela https://orcid.org/0000-0002-3478-8065
-
Funding
Funding for this research was provided by:
Cancer Research UK (A19277)
Cancer Research UK (CM1406)
- License Information
-
More Information
Article History
Received: 8 January 2021
Revised: 22 July 2021
Accepted: 27 July 2021
First Online: 17 September 2021
Conflict of interest
: MJW is co‐founder and non‐executive director of and has equity interest in Evox Therapeutics. All other authors declare that they have no conflict of interest.
